REFG Medical Cannabis Payment Solutions

Pneumonia Vaccines Take a Bold Step GPN Vaccines is steering its course with a US$10 million private placement, aiming to shake up a traditionally complex vaccine market. This clinical-stage biotech is throwing down the gauntlet with Gamma-PN™, its lead candidate that challenges existing serotype-specific pneumococcal vaccines. The big idea? Bypass the mess of adding...

Helping Veterans: A Call That Never Fades If there's one thing that never changes, it's the enduring need to support those who have served. Semper Fi & America's Fund has been at the forefront of this mission for over a decade, and their annual Double Down for Veterans Match Campaign is nothing short of a testament to unwavering commitment. Kicking off for the 15th time,...

Lupin's Big Break Let's cut right to the chase: Lupin's latest FDA approval is no small potatoes. It's like getting a golden ticket in the pharma world, especially when you've been in the trenches as long as they have. As the first-to-file for their Amifampridine Tablets, 10 mg, this Indian giant is snagging that sweet 180-day exclusivity window. And in the cutthroat...

Transforming Fundraising with a Marketplace Twist Sometimes the real treasures are not tucked in textbooks but found in cluttered closets and basements. Enter One Stop Swap with a big idea—they're cooking up a fundraising strategy for schools that could shake things up by helping families sell their unused stuff. It's got that grassroots vibe with the potential to carve...

Another Step Forward at Murdock Mountain In the cutthroat world of mining exploration, hitting that sweet spot between expectation and reality is akin to finding gold. So, when Nevada Organic Phosphate Inc. (CSE: NOP, OTCQB: NOPFF) touts another solid intersection at their Murdock Mountain site, I figure it's worth a closer look. Drill Hole MM26-13, the latest contender,...

A Fresh Approach to Banking in Bahrain The stuff that's stirring the pot in Bahrain’s financial sector right now? This big ol' partnership between Mumtalakat, the Kingdom's sovereign wealth fund, and ARP Group. They're on a mission to launch an AI-native wholesale bank smack dab in Bahrain. But here’s the kicker – they’ve got the green light, in principle at...

New Flexibility at the Beauty Checkout Hey, if you've ever paced back and forth considering signing up for that luxury self-care spree, well, Fresha’s latest move might just tip the scales. The beauty and wellness booking giant has partnered with Klarna, diving headfirst into the Buy Now, Pay Later (BNPL) craze. It's about time, right? Everyone loves a good spa session,...

Investors Eye Deadline Amidst Legal Storm Holy moly, Tenax Therapeutics is caught with their pants down—and we're not talking loose change. Any sorry soul who bought into Tenax's promises about their TNX-103 drug is now staring down a high-stakes class action lawsuit. If you were holding on to those dreams turned nightmares between November 13, 2023, and August 7, 2026,...

Another Feather in HIZENERGY's Cap In a landscape where credibility can make or break a business, HIZENERGY has once again staked its claim as a powerhouse. Come Q4 2026, and despite a rougher sea to navigate with BloombergNEF’s (BNEF) upgraded Tier 1 criteria, the company held its own. For those unacquainted, securing a place on this lofty list involves some serious...

Decoding PSEG's Q3 2026 Performance A company's quarterly performance can feel a bit like checking the weather: you are never quite sure what's coming your way. For PSEG's (NYSE: PEG) third quarter of 2026, the skies were full of mixed signals. Just looking at the headline earnings number, $0.76 per share in net income, there's a drop from last year's $1.24. That’s a...

Manufacturing’s Talent Challenges in the Era of Industry 5.0 As we transition from Industry 4.0 to Industry 5.0, the focus is shifting dramatically towards a more human-centric approach. This evolution presents a pressing challenge for manufacturers: a growing skills crisis in IT. Organizations now face the daunting task of not only acquiring technology but also...

Eisai Submits New Dosing Variation for Leqembi Eisai recently announced the submission of a proposed Marketing Authorization Variation to the European Medicines Agency (EMA) for lecanemab, marketed as Leqembi. This initiative aims to establish a maintenance dosing regimen for lecanemab that will allow for intravenous (IV) infusion every four weeks, enhancing the...

Pallet secured an impressive $18 million in Series A funding back in early 2023, aiming to revolutionize the logistics landscape. You know how this game works; cash infusions get the buzz going, and Bain Capital Ventures led this round with notable support from Bessemer Venture Partners and Activant Capital. Adding some flair were angel investors like Zach Frankel and...

Grief Coach University Steps Up After Hurricane Helene In the wake of Hurricane Helene, the need for grief coaching has become critical. Grief Coach University (Grief Coach U) is answering the call by providing essential support for communities facing emotional turmoil. Following the devastation of such disasters, many individuals struggle with their mental health,...

Upcoming Financial Results Announcement from Telos Corporation Telos Corporation (NASDAQ: TLS), known for its cutting-edge cyber, cloud, and enterprise security solutions, has announced it will unveil its financial results for the third quarter. This corporate event is set to take place on a Monday morning, marking an important moment for investors and stakeholders alike....